Abstract
To describe the pharmacokinetics of abacavir 600 mg once daily (q.d.) in HIV-1-positive women during pregnancy and postpartum. A nonrandomized, open-label, multicentre, phase-IV study. HIV-positive pregnant women receiving abacavir 600 mg q.d. as part of clinical care were included. Intensive 24-h pharmacokinetic sampling was performed during the third trimester and at least 2 weeks after delivery. Pharmacokinetic parameters were calculated by noncompartmental analysis. Paired cord blood and maternal blood samples were taken at delivery when feasible. A total of 14 women were included in the analysis. Geometric mean ratios (90% confidence intervals) of third trimester versus postpartum were 1.05 (0.92-1.19) for AUC0-24h and 1.00 (0.83-1.21) for Cmax. The median (range) ratio of abacavir cord plasma to maternal plasma was 1.0 (0.7-1.0, n = 3). Viral load at the third trimester visit was less than 50 copies/ml in 13 participants (93%; one unknown). In total, 13 (93%; one unknown) children were tested HIV-negative. The pharmacokinetics of abacavir 600 mg q.d. during pregnancy are equivalent to postpartum. No dose adjustments are required during pregnancy and similar antiviral activity is expected.
References
May 1, 1997·Antimicrobial Agents and Chemotherapy·S M DalugeT A Krenitsky
Jul 18, 2000·Antimicrobial Agents and Chemotherapy·S WellerD S Stein
Oct 27, 2004·Antimicrobial Agents and Chemotherapy·Hélène ChappuyLaurent Mandelbrot
Jan 25, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·C P W G M Verweij-van WissenD M Burger
Feb 14, 2006·AIDS·Brookie M BestUNKNOWN PACTG P1026s Study Team
Jun 17, 2006·Therapeutic Drug Monitoring·Diane T HollandGene D Morse
Sep 14, 2007·American Journal of Obstetrics and Gynecology·Norma S HarrisMargaret A Lampe
May 16, 2008·Clinical Pharmacokinetics·Geoffrey J YuenGary E Pakes
Jan 24, 2012·Antiviral Therapy·Akil JacksonMarta Boffito
Apr 21, 2012·Clinical Pharmacokinetics·Khaled AbduljalilHora Soltani
Nov 22, 2012·AIDS·Angela P H ColbersUNKNOWN PANNA network
Nov 2, 2013·AIDS·Roger L ShapiroMax Essex
Feb 26, 2014·AIDS·Claire L TownsendPat A Tookey
Jul 30, 2014·Antimicrobial Agents and Chemotherapy·Floris FauchetDéborah Hirt
Sep 17, 2014·Clinical Pharmacokinetics·Shelley A McCormack, Brookie M Best
Oct 19, 2014·The Journal of Antimicrobial Chemotherapy·Angela ColbersUNKNOWN PANNA Network
Dec 4, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Vani VannappagariConway Gee
Aug 25, 2015·Pharmacotherapy·Elise M GilbertMilena M McLaughlin
Citations
Jun 9, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stein SchalkwijkUNKNOWN Pharmacokinetics of newly developed antiretroviral agents in HIV-infected pregnant women (PANNA) Network
Mar 22, 2019·Current Pharmaceutical Design·E M HodelN Rakhmanina
Sep 19, 2019·Journal of the International AIDS Society·Lee FairlieMatthew Chersich
Jun 28, 2020·Journal of Pharmacokinetics and Pharmacodynamics·Khaled Abduljalil, Raj K Singh Badhan
Jun 28, 2021·AIDS·Julian C GilmoreReina Bendayan